UB-165: A novel nicotinic agonist with subtype selectivity implicates the α4β2* subtype in the modulation of dopamine release from rat striatal synaptosomes

Journal of Neuroscience

Volumn 20, Issue 8, 2000, Pages 2783-2791

  Sharples, Christopher G V ^a   Kaiser, Sergio ^a,e   Soliakov, Lev ^a   Marks, Michael J ^b   Collins, Allan C ^b   Washburn, Mark ^c   Wright, Emma ^d   Spencer, James A ^d   Gallagher, Timothy ^d   Whiteaker, Paul ^b   Wonnacott, Susan ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF COLORADO   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine release; Neuronal nicotinic acetylcholine receptor; Presynaptic nicotinic modulation; Rat striatal synaptosomes; SH SY5Y cells; Xenopus oocytes; conotoxin

Indexed keywords

ANATOXIN; CONOTOXIN; DOPAMINE; EPIBATIDINE; NICOTINIC AGENT; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SYNAPTOSOME; XENOPUS;

EID: 0034655721     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-08-02783.2000     Document Type: Article

References (47)

1. Alkondon M, Albuquerque EX (1995) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J Pharmacol Exp Ther 274:771-782.
2. Alkondon M, Pereira EF, Albuquerque EX (1998) Alpha-bungarotoxin-and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810:257-263.
3. Bencherif M, Schmitt JD, Bhatti BS, Crooks P, Caldwell WS, Lovette ME, Fowler K, Reeves L, Lippiello PM (1998) The heterocyclic substituted pyridinc derivative (±)-2-(-3-pyridinyl)-1-azabicyclo [2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors. J Pharmacol Exp Ther 284:886-894.
4. Cartier GE, Yoshokami D, Gray WR, Luo S, Olivera BM, McIntosh JM (1996) A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271:7522-7528.
5. Charpantier E, Barneoud P, Moser P, Besnard F, Sgard F (1998) Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. NeuroReport 9:3097-3101.
6. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346-356.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3089-3108.
8. Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358.
9. Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905-908.
10. 3H]methylycaconitine: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors. Neuropharmacology 38:679-690.
11. Decker MW, Arneric SP (1998) Nicotinic acetylcholine receptor-targeted compounds: a summary of the developmental pipeline and therapeutic potential. In: Neuronal nicotinic receptors, pharmacology and therapeutic opportunities (Arneric SP, Brioni JD, eds), pp 395-411. New York: Wiley.
12. Deneris ES, Boulter J, Swanson LW, Patrick J, Heinemann S (1989) Beta3: A new member of nicotinic acetylcholine receptor gene family is expressed in brain. J Biol Chem 264:6268-6272.
13. Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC, Velicelebi G, Harpold MM (1996) Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits. J Mol Neurosci 7:217-228.
14. El-Bizri H, Clarke PBS (1994) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br J Pharmacol 111:406-413.
15. Fenster CP, Whitworth TL, Sheffield EB, Quick MW, Lester RAJ (1999) Up-regulation of surface α4β2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci 19: 4804-4814.
16. Frazier CJ, Buhler AV, Weiner JL, Dunwiddle TV (1998) Synaptic potentials mediated via α-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci 18:8228-8235.
17. Fucile S, Matter J-M, Erkman L, Ragozzino D, Barabino B, Grassi F, Alemà S, Ballivet M, Eusebi F (1998) The neuronal alpha6 subunit forms heteromeric acetylcholine receptors in human transfected cells. Eur J Neurosci 10:172-178.
18. Garcha HS, Thomas P, Spivak CE, Wonnacott S, Stolerman IP (1993) Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. Psychopharmacology 110:347-354.
19. 3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856.
20. 3H]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment. J Pharmacol Exp Ther 282:32-43.
21. Grady SR, Lu Y, Picciotto MR, Changeux J-P, Collins AC (1998) Nicotine-stimulated synaptosomal neurotransmitter release from β2 null mutant mice. Soc Neurosci Abstr 28:530, 15.
22. Groot-Kormelink PJ, Luyten WH, Colquhoun D, Sivilotti LG (1998) A reporter mutation approach shows incorporation of the "orphan" subunit beta3 into a functional nicotinic receptor. J Biol Chem 273:15317-15320.
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
24. Holladay MW, Dart MJ, Lynch JK (1997) Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J Med Chem 40:4169-4194.
25. 3H]dopamine release from rat striatal synaptosomes and slices. J Neurochem 70:1069-1076.
26. Kulak JM, Nguyen TA, Olivera BM, McIntosh JM (1997) α-Conotoxin MII blocks nicotine-stimulated dopaminc release in rat striatal synaptosomes. J Neurosci 17:5263-5270.
27. Le Novèrc N, Zoli M, Changeux J-P (1996) Neuronal nicotine receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur J Neurosci 8:2428-2439.
28. Lukas RJ, Norman SA, Lucero L (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol Cell Neurosci 4:1-12.
29. Lukas RJ, Changeux J-P, le Novère N, Albuquerque EX, Balfour DJK, Berg DK, Bertrand D, Chiappinelli VA, Clarke PBS, Collins AC, Dani JA, Grady SA, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, Wonnacott S (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51:397-401.
30. Marks MJ, Farnham DA, Grady SR, Collins AC (1993) Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther 264:542-552.
31. + efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther 277:1383-1396.
32. Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, Picciotto MR, Changeux J-P, Collins AC (1999) Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the β2 subunit. J Pharmacol Exp Ther 289:1090-1103.
33. McIntosh JM, Santos AD, Olivera BM (1999) Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu Rev Biochem 68:59-88.
34. Murphy NP, Vaughan PFT, Ball SG, McCormack JG (1991) The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y. J Neurochem 57:2116-2123.
35. Peng X, Katz M, Gerzanich V, Anand R, Lindstrom J (1994) Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol Pharmacol 45:546-554.
36. 3H]dopamine release from striatal synaptosomes: pharmacological characterisation. J Neurochem 54:937-945.
37. Role LW, Berg DK (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085.
38. 3H]nicotine eliminates low affinity binding. Life Sci 46:935-945.
39. Sacaan AI, Dunlop JL, Lloyd GK (1995) Pharmacological characterisation of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J Pharmacol Exp Ther 274:224-230.
40. 3H]dopamine release from rat striatal synaptosomes. J Neurochem 67:163-170.
41. 3H]-dopamine release from rat striatal synaptosomes. Neuropharmacology 34:1535-1541.
42. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson L (1989) Distribution of alpha2, alpha3, alpha4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284:314-335.
43. Wang F, Gerzanich V, Wells G, Anand R, Peng X, Keyser K, Lindstrom J (1996) Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2 and β4 subunits. J Biol Chem 271:17656-17685.
44. Whitcaker P, Sharples CGV, Wonnacott S (1998) Agonist induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 53:950-962.
45. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Pharmacol Sci 20:92-98.
46. Wright E, Gallagher T, Sharples CGV, Wonnacott S (1997) Synthesis of UB-165: a novel nicotinic ligand and anatoxin-a/epibatidine hybrid. Bioorg Med Chem Lett 7:2867-2870.
47. Zoli M, Léna C, Picciotto MR, Changeux J-P (1998) Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 18:4461-4472.